1. Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages
   Tania Reyes-Vallejo et al, 2022, OncoTargets and Therapy CrossRef
2. Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure
   Diego José Laderach et al, 2021, Cancers CrossRef
3. Galectin-9, a pro-survival factor inducing immunosuppression, leukemic cell transformation and expansion
   Cansu Yıldırım, 2024, Molecular Biology Reports CrossRef
4. The role of galectins in mediating the adhesion of circulating cells to vascular endothelium
   Joseph Souchak et al, 2024, Frontiers in Immunology CrossRef
5. Human T cell glycosylation and implications on immune therapy for cancer
   Elien De Bousser et al, 2020, Human Vaccines & Immunotherapeutics CrossRef
6. Design, Synthesis, and Anticancer Activity of a Selenium-Containing Galectin-3 and Galectin-9N Inhibitor
   Sonia Di Gaetano et al, 2022, International Journal of Molecular Sciences CrossRef